Axon Enterprise earnings were $326.3M for the trailing 12 months ending Jun 30, 2025, with 9.5% growth year over year. The latest AXON earnings report on Jun 30, 2025 announced Q2 2025 earnings of $36.1M, down 58.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AXON reported annual earnings of $377.0M, with 114.5% growth. The next AXON earnings date is Nov 6, 2025.
AXON past earnings growth
How has AXON's earnings growth performed historically?
What were Axon Enterprise's earnings last quarter?
On AXON's earnings call on Invalid Date, Axon Enterprise (NASDAQ: AXON) reported Q2 2025 earnings per share (EPS) of $0.46, up 16.36% year over year. Total AXON earnings for the quarter were $36.12 million. In the same quarter last year, Axon Enterprise's earnings per share (EPS) was $0.55.
The next AXON earnings call is Invalid Date. Add AXON to your watchlist to be reminded of Axon Enterprise's next earnings date.
Is Axon Enterprise profitable or losing money?
As of the last Axon Enterprise earnings report, Axon Enterprise is currently profitable. Axon Enterprise's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $326.31 million, a 11.29% increase year over year.
What was AXON's earnings growth in the past year?
As of Axon Enterprise's earnings date in Invalid Date, Axon Enterprise's earnings has grown 9.49% year over year. This is 33.28 percentage points lower than the US Aerospace & Defense industry earnings growth rate of 42.77%. AXON earnings in the past year totalled $326.31 million.
What are Axon Enterprise's earnings expectations?
The current EPS estimate for Axon Enterprise's earnings report in Invalid Date is $1.51.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.